These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34687785)

  • 1. SARS-CoV-2 microfluidic antigen point-of-care testing in Emergency Room patients during COVID-19 pandemic.
    Burdino E; Cerutti F; Panero F; Allice T; Gregori G; Milia MG; Cavalot G; Altavilla A; Aprà F; Ghisetti V
    J Virol Methods; 2022 Jan; 299():114337. PubMed ID: 34687785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an antigen-based test for hospital point-of-care diagnosis of SARS-CoV-2 infection.
    Bianco G; Boattini M; Barbui AM; Scozzari G; Riccardini F; Coggiola M; Lupia E; Cavallo R; Costa C
    J Clin Virol; 2021 Jun; 139():104838. PubMed ID: 33946040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the LumiraDx Microfluidic Immunofluorescence Point-of-Care SARS-CoV-2 Antigen Test in Asymptomatic Adults and Children.
    Drain P; Sulaiman R; Hoppers M; Lindner NM; Lawson V; Ellis JE
    Am J Clin Pathol; 2022 Apr; 157(4):602-607. PubMed ID: 34668536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point of care molecular and antigen detection tests for COVID-19: current status and future prospects.
    Stokes W; Berenger BM; Venner AA; Deslandes V; Shaw JLV
    Expert Rev Mol Diagn; 2022 Aug; 22(8):797-809. PubMed ID: 36093682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparing for the next pandemic: lessons learnt from the implementation of point-of-care SARS-CoV-2 testing in an emergency department.
    Donnelly JA; Russell M; O'Brien G; O'Neill I; Fitzpatrick F; O'Connell K
    J Clin Pathol; 2023 Sep; 76(9):642-646. PubMed ID: 37193583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An all-in-one point-of-care testing device for multiplexed detection of respiratory infections.
    Teixeira W; Pallás-Tamarit Y; Juste-Dolz A; Sena-Torralba A; Gozalbo-Rovira R; Rodríguez-Díaz J; Navarro D; Carrascosa J; Gimenez-Romero D; Maquieira Á; Morais S
    Biosens Bioelectron; 2022 Oct; 213():114454. PubMed ID: 35696866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Fast SARS-CoV-2 Molecular Point-Of-Care Testing on Patients' Length of Stay in an Emergency Department.
    Baron A; Peyrony O; Salmona M; Mahjoub N; Ellouze S; Anastassiou M; Delaugerre C; Fontaine JP; Chevret S; LeGoff J; Feghoul L
    Microbiol Spectr; 2022 Aug; 10(4):e0063622. PubMed ID: 35730967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frontline Screening for SARS-CoV-2 Infection at Emergency Department Admission by Third Generation Rapid Antigen Test: Can We Spare RT-qPCR?
    Cento V; Renica S; Matarazzo E; Antonello M; Colagrossi L; Di Ruscio F; Pani A; Fanti D; Vismara C; Puoti M; Scaglione F; Perno CF; Alteri C; On Behalf Of The S Co Va Study Group
    Viruses; 2021 May; 13(5):. PubMed ID: 34062916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field Evaluation of the New Rapid NG-Test
    Avgoulea K; Beredaki MI; Vourli S; Siopi M; Siafakas N; Pournaras S
    Front Public Health; 2022; 10():840984. PubMed ID: 35548072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point-of-care COVID-19 antigen testing in German emergency rooms - a cost-benefit analysis.
    Diel R; Nienhaus A
    Pulmonology; 2022; 28(3):164-172. PubMed ID: 34315687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting.
    Osterman A; Baldauf HM; Eletreby M; Wettengel JM; Afridi SQ; Fuchs T; Holzmann E; Maier A; Döring J; Grzimek-Koschewa N; Muenchhoff M; Protzer U; Kaderali L; Keppler OT
    Med Microbiol Immunol; 2021 Feb; 210(1):65-72. PubMed ID: 33452927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.
    Wolters F; van de Bovenkamp J; van den Bosch B; van den Brink S; Broeders M; Chung NH; Favié B; Goderski G; Kuijpers J; Overdevest I; Rahamat-Langedoen J; Wijsman L; Melchers WJ; Meijer A
    J Clin Virol; 2020 Jul; 128():104426. PubMed ID: 32417674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can we trust in Sars-CoV-2 rapid antigen testing? Preliminary results from a paediatric cohort in the emergency department.
    Denina M; Giannone V; Curtoni A; Zanotto E; Garazzino S; Urbino AF; Bondone C
    Ir J Med Sci; 2022 Aug; 191(4):1767-1770. PubMed ID: 34519927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fast, Reliable, and Simple Point-of-Care-like Adaptation of RT-qPCR for the Detection of SARS-CoV-2 for Use in Hospital Emergency Departments.
    Pavletić M; Mazor M; Lerga M; Mileta T; Železnjak J; Ružić T; Ravlić S; Palčevski D; Kirinčić J; Mežnarić S; Mišković A; Materljan M; Šustić A; Lisnić B; Juranić Lisnić V
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a rapid antigen detection test (Panbio™ COVID-19 Ag Rapid Test Device) as a point-of-care diagnostic tool for COVID-19 in a pediatric emergency department.
    Carbonell-Sahuquillo S; Lázaro-Carreño MI; Camacho J; Barrés-Fernández A; Albert E; Torres I; Bretón-Martínez JR; Martínez-Costa C; Navarro D
    J Med Virol; 2021 Dec; 93(12):6803-6807. PubMed ID: 34289136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of a SARS-CoV-2 Antigen Rapid Immunoassay Based on Active Microfluidic Technology in a Setting of Children and Young Adults.
    Leli C; Ferrara L; Bottino P; Bara C; Megna I; Penpa S; Felici E; Maconi A; Rocchetti A
    Viruses; 2023 Dec; 16(1):. PubMed ID: 38257741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary SARS-CoV-2 antigen rapid detection: A prospective cohort study.
    Basso D; Aita A; Padoan A; Cosma C; Navaglia F; Moz S; Contran N; Zambon CF; Maria Cattelan A; Plebani M
    Clin Chim Acta; 2021 Jun; 517():54-59. PubMed ID: 33626369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of ID NOW COVID-19 assay used as point-of-care test in an emergency department.
    NguyenVan JC; Gerlier C; Pilmis B; Mizrahi A; Péan de Ponfilly G; Khaterchi A; Enouf V; Ganansia O; Le Monnier A
    J Clin Virol; 2021 Dec; 145():105021. PubMed ID: 34768231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2.
    Cerutti F; Burdino E; Milia MG; Allice T; Gregori G; Bruzzone B; Ghisetti V
    J Clin Virol; 2020 Nov; 132():104654. PubMed ID: 33053494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microfluidic point-of-care device for detection of early strains and B.1.1.7 variant of SARS-CoV-2 virus.
    Lim J; Stavins R; Kindratenko V; Baek J; Wang L; White K; Kumar J; Valera E; King WP; Bashir R
    Lab Chip; 2022 Mar; 22(7):1297-1309. PubMed ID: 35244660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.